Thank you, Mr. Chair.
I'll turn back to Mr. Lamarre.
On February 16, exactly four months ago, you testified before the Standing Committee on Industry, Science and Technology.
I asked you a question about the pitfalls to avoid. You responded that we shouldn't focus on a limited number of technologies based on individual concerns that aren't part of a global vision, and that we also shouldn't focus solely on the vaccine development chain without maintaining a strong basic research capacity.
We know that messenger RNA technology was developed through basic research over 40 years ago and that this technology is saving us today.
Have things changed on the ground in the past four months? Is the government keeping its promises?